Secondary objective A: Assess feasibility of test‐and‐treat strategy for influenza in shelters
INFLUENZA
Feasibility of implementation of point‐of‐care influenza molecular testing was measured as the time between symptom onset until diagnosis through rapid test or laboratory test. Feasibility of implementation of antiviral treatment was measured as the time between symptom onset until initiation of antiviral treatment. Additional endpoints used to characterize feasibility were proportion of participants lost‐to‐follow‐up (LTFU) and proportion of participants non‐compliant with oseltamivir therapy (self‐reported measure collected during on‐site follow‐up visits with kiosk staff).